Notice
Recent Posts
Recent Comments
| 일 | 월 | 화 | 수 | 목 | 금 | 토 |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 |
Tags
- case study
- Acquistion
- China
- acquisition
- securities
- CA
- Letter of intent
- Japan
- M&A
- Merger
- Malaysia
- LOTTE
- sk
- nda
- buyout
- taiwan
- Japan Tobacco
- Korea M&A
- Bank
- LOI
- China Construction Bank
- private equity
- PEF
- Korea
- OTCBB
- hong kong
- Investment
- Confidential Agreement
- capital gate
- cgi korea
Archives
- Today
- Total
Korea M&A Corporation
Eisai’s $3.9 Billion Parachute: MGI Pharma
Eisai said this morning that it’s dropping $3.9 billion in cash to pick up MGI Pharma, a Minnesota-based company that sells cancer drugs. Consider the deal a parachute for the company to wear when it falls off the patent cliff in 2010, as its biggest selling drug, the Alzheimer’s medicine Aricept, loses patent protection. The Japanese drug business has been struggling — prompting the nation’s he..
News/M&A
2007. 12. 15. 08:53